Literature DB >> 9705234

Three new mutations in a gene causing Hermansky-Pudlak syndrome: clinical correlations.

V Shotelersuk1, S Hazelwood, D Larson, F Iwata, M I Kaiser-Kupfer, E Kuehl, I Bernardini, W A Gahl.   

Abstract

Hermansky-Pudlak syndrome (HPS) consists of oculocutaneous albinism, a platelet storage pool deficiency, and ceroid lipofuscinosis. HPS is common in northwest Puerto Rico, where affected individuals are homozygous for a 16-bp duplication in the gene HPS. Two other homozygous frameshift mutations in HPS were previously identified among non-Puerto Rican patients. Eighteen non-Puerto Rican HPS families were studied and HPS mutations in three of them identified. One mutation, T322insC, has been previously described. However, three additional mutations, E133X, T322delC, and S396delC, have not been reported. Two families exhibited compound heterozygosity for these mutations, although most previously reported HPS patients have been homozygous for a particular mutation. All the newly described mutations were associated with decreased or undetectable levels of HPS RNA by Northern blot analysis of fibroblasts, and all had significant pigment dilution. To date, all mutations in HPS result in a truncated protein, suggesting that the C-terminal portion of the HPS protein is functionally important. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9705234     DOI: 10.1006/mgme.1998.2679

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  10 in total

1.  The genomic region encompassing the nephropathic cystinosis gene (CTNS): complete sequencing of a 200-kb segment and discovery of a novel gene within the common cystinosis-causing deletion.

Authors:  J W Touchman; Y Anikster; N L Dietrich; V V Maduro; G McDowell; V Shotelersuk; G G Bouffard; S M Beckstrom-Sternberg; W A Gahl; E D Green
Journal:  Genome Res       Date:  2000-02       Impact factor: 9.043

2.  Melanocyte-specific proteins are aberrantly trafficked in melanocytes of Hermansky-Pudlak syndrome-type 3.

Authors:  Raymond E Boissy; Bonnie Richmond; Marjan Huizing; Amanda Helip-Wooley; Yang Zhao; Amy Koshoffer; William A Gahl
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

3.  Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype.

Authors:  Richard A King; Jacy Pietsch; James P Fryer; Sarah Savage; Marcia J Brott; Isabelle Russell-Eggitt; C Gail Summers; William S Oetting
Journal:  Hum Genet       Date:  2003-09-10       Impact factor: 4.132

4.  A divalent interaction between HPS1 and HPS4 is required for the formation of the biogenesis of lysosome-related organelle complex-3 (BLOC-3).

Authors:  Carmelo Carmona-Rivera; Dimitre R Simeonov; Nicholas D Cardillo; William A Gahl; Carmen L Cadilla
Journal:  Biochim Biophys Acta       Date:  2012-10-23

5.  Alveolar macrophage dysregulation in Hermansky-Pudlak syndrome type 1.

Authors:  Farshid N Rouhani; Mark L Brantly; Thomas C Markello; Amanda Helip-Wooley; Kevin O'Brien; Richard Hess; Marjan Huizing; William A Gahl; Bernadette R Gochuico
Journal:  Am J Respir Crit Care Med       Date:  2009-09-03       Impact factor: 21.405

6.  Clinical, molecular, and cellular features of non-Puerto Rican Hermansky-Pudlak syndrome patients of Hispanic descent.

Authors:  Carmelo Carmona-Rivera; Gretchen Golas; Richard A Hess; Nicholas D Cardillo; Elijah H Martin; Kevin O'Brien; Ekaterini Tsilou; Bernadette R Gochuico; James G White; Marjan Huizing; William A Gahl
Journal:  J Invest Dermatol       Date:  2011-08-11       Impact factor: 8.551

7.  Genetic analyses of Vietnamese patients with oculocutaneous albinism.

Authors:  Ma Thi Huyen Thuong; Luong Thi Lan Anh; Vu Phuong Nhung; Tran Thi Bich Ngoc; Hoang Thu Lan; Doan Kim Phuong; Nguyen Hai Ha; Nong Van Hai; Nguyen Dang Ton
Journal:  J Clin Lab Anal       Date:  2022-07-23       Impact factor: 3.124

8.  Oculocutaneous albinism and bleeding diathesis due to a novel deletion in the HPS3 gene.

Authors:  Dina Marek-Yagel; Shachar Abudi-Sinreich; Michal Macarov; Alvit Veber; Nechama Shalva; Amit Mary Philosoph; Ben Pode-Shakked; May Christine V Malicdan; Yair Anikster
Journal:  Front Genet       Date:  2022-08-15       Impact factor: 4.772

9.  Disruption of AP3B1 by a chromosome 5 inversion: a new disease mechanism in Hermansky-Pudlak syndrome type 2.

Authors:  Matthew L Jones; Sherina L Murden; Claire Brooks; Viv Maloney; Richard A Manning; Kimberly C Gilmour; Vandana Bharadwaj; Josu de la Fuente; Subarna Chakravorty; Andrew D Mumford
Journal:  BMC Med Genet       Date:  2013-04-04       Impact factor: 2.103

10.  Hermansky-Pudlak syndrome: Mutation update.

Authors:  Marjan Huizing; May C V Malicdan; Jennifer A Wang; Hadass Pri-Chen; Richard A Hess; Roxanne Fischer; Kevin J O'Brien; Melissa A Merideth; William A Gahl; Bernadette R Gochuico
Journal:  Hum Mutat       Date:  2020-01-23       Impact factor: 4.700

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.